HEPATITIS A VIRUS STRAIN 326F ANTIGEN: 46 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
46
Total FAERS Reports
2 (4.3%)
Deaths Reported
11
Hospitalizations
46
As Primary/Secondary Suspect
4
Life-Threatening
4
Disabilities
Merck Sharp & Dohme LLC
Manufacturer
Drug Class: Actively Acquired Immunity [PE] · Manufacturer: Merck Sharp & Dohme LLC ·
First Report: 200010 · Latest Report: 20250329
What Are the Most Common HEPATITIS A VIRUS STRAIN 326F ANTIGEN Side Effects?
#1 Most Reported
No adverse event
23 reports (50.0%)
#2 Most Reported
Product storage error
12 reports (26.1%)
#3 Most Reported
Asthenia
10 reports (21.7%)
All HEPATITIS A VIRUS STRAIN 326F ANTIGEN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| No adverse event | 23 | 50.0% | 0 | 0 |
| Product storage error | 12 | 26.1% | 0 | 0 |
| Asthenia | 10 | 21.7% | 0 | 10 |
| Loss of personal independence in daily activities | 8 | 17.4% | 0 | 8 |
| Diarrhoea | 7 | 15.2% | 0 | 6 |
| Paraesthesia | 7 | 15.2% | 0 | 6 |
| Abdominal discomfort | 6 | 13.0% | 0 | 6 |
| Acute sinusitis | 6 | 13.0% | 0 | 6 |
| Cardiovascular disorder | 6 | 13.0% | 0 | 6 |
| Cognitive disorder | 6 | 13.0% | 0 | 6 |
| Coordination abnormal | 6 | 13.0% | 0 | 6 |
| Cough | 6 | 13.0% | 0 | 6 |
| Dizziness | 6 | 13.0% | 0 | 6 |
| Fatigue | 6 | 13.0% | 0 | 6 |
| Gait disturbance | 6 | 13.0% | 0 | 6 |
| Gastroenteritis | 6 | 13.0% | 0 | 6 |
| Hypoaesthesia | 6 | 13.0% | 0 | 6 |
| Irritable bowel syndrome | 6 | 13.0% | 0 | 6 |
| Malaise | 6 | 13.0% | 0 | 6 |
| Multiple sclerosis | 6 | 13.0% | 0 | 6 |
Who Reports HEPATITIS A VIRUS STRAIN 326F ANTIGEN Side Effects? Age & Gender Data
Gender: 41.9% female, 58.1% male. Average age: 22.8 years. Most reports from: US. View detailed demographics →
Is HEPATITIS A VIRUS STRAIN 326F ANTIGEN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 2 | 0 | 2 |
| 2001 | 4 | 0 | 4 |
| 2012 | 1 | 0 | 0 |
| 2016 | 2 | 0 | 0 |
| 2017 | 5 | 0 | 0 |
| 2018 | 8 | 0 | 5 |
| 2019 | 1 | 0 | 0 |
| 2020 | 1 | 0 | 0 |
| 2021 | 3 | 0 | 0 |
| 2023 | 2 | 0 | 0 |
| 2024 | 3 | 0 | 0 |
| 2025 | 1 | 0 | 0 |
What Is HEPATITIS A VIRUS STRAIN 326F ANTIGEN Used For?
| Indication | Reports |
|---|---|
| Prophylaxis | 38 |
Other Drugs in Same Class: Actively Acquired Immunity [PE]
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN (2,002)
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (1,937)
YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN (79)
HUMAN ROTAVIRUS A TYPE G1P STRAIN RIX4414 LIVE ANTIGEN (56)
HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (45)
HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN (27)
HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN (24)
SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN (20)
View all →
Class side effects →
Compare in class →
Official FDA Label for HEPATITIS A VIRUS STRAIN 326F ANTIGEN
Official prescribing information from the FDA-approved drug label.